GLMD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Galmed Pharmaceuticals Ltd (GLMD) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock lacks positive financial performance, significant trading trends, or catalysts to support a long-term growth outlook. Additionally, technical indicators and trading signals do not suggest a strong entry point.
The MACD is slightly positive at 0.0107, indicating mild bullish momentum, but the RSI at 61.153 is neutral, providing no clear signal. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), suggesting a downward trend. The stock is trading near resistance levels (R1: 0.667), which may limit upside potential.
NULL identified. No recent news, no significant hedge fund or insider trading activity, and no congress trading data available.
Revenue and gross margin remain at zero, indicating poor financial health. No recent news or events to drive positive sentiment.
In Q3 2025, the company showed no revenue growth (0% YoY) and a significant decline in EPS (-84.85% YoY). Net income remains negative at -$1,892,000, reflecting poor profitability.
No data available for analyst ratings or price target changes.
